A new chimeric monoclonal CD4 antibody for prevention of rejection after heart transplantation

Transplant Proc. 1992 Oct;24(5):1734.

Authors

B M Meiser¹, C Reiter, M Ebel, P Uberfuhr, K Wenke, H Reichenspurner, E Rieber, G Riethmüller, B Reichart

Affiliation

¹ Department of Cardiac Surgery, Ludwig-Maximilians University of Munich, Germany.

PMID: 1412816

No abstract available

Publication types

Clinical Trial
Comparative Study
Randomized Controlled Trial

MeSH terms

Adrenal Cortex Hormones / therapeutic use
Antibodies, Monoclonal / therapeutic use*
Antilymphocyte Serum / therapeutic use*
Azathioprine / therapeutic use
CD4 Antigens / immunology*
Cyclosporine / therapeutic use
Graft Rejection / prevention & control*
Heart Transplantation / immunology*
Humans
Recombinant Fusion Proteins / therapeutic use*
Time Factors

Substances

Adrenal Cortex Hormones
Antibodies, Monoclonal
Antilymphocyte Serum
CD4 Antigens
Recombinant Fusion Proteins
Cyclosporine
Azathioprine